Veozah is a medicine for hot flashes and night sweats caused by menopause. It is a pill taken by mouth once a day and does not contain hormones. It works by blocking a brain signal that controls body temperature.
Every report comes from a Lived member, sent anonymously.
Have you tried Veozah (Fezolinetant) for Hot Flashes?
Fezolinetant, sold as Veozah, is a prescription tablet for moderate to severe hot flashes and night sweats caused by menopause. Doctors call these vasomotor symptoms: sudden waves of heat, flushing and sweating that can disrupt sleep, work and daily life. It is approved for adults; its safety and effectiveness have not been established in anyone under 18. Veozah contains no hormones. That makes it one option for people who cannot use hormone therapy, such as some people with estrogen-sensitive cancers or heart and blood vessel disease, and for those who would rather avoid it. Hormone therapy is still the most effective treatment for hot flashes, and other nonhormonal choices exist, including some antidepressants and gabapentin. The Menopause Society lists fezolinetant among the nonhormonal treatments with good, consistent evidence.
A small area deep in the brain, the hypothalamus, acts as the body's thermostat. Nerve cells there pass along signals related to estrogen, using a chemical messenger called neurokinin B. After menopause, as estrogen falls, these cells change and their neurokinin B signaling appears to become overactive. Researchers think this makes the thermostat misread normal body temperature as too hot, setting off flushing and sweating to cool down. Fezolinetant blocks the receptor neurokinin B acts on, the neurokinin 3 (NK3) receptor. This quiets the overactive signal so the thermostat is triggered less often, and hot flashes become less frequent and somewhat less intense. It does this without replacing estrogen, and in studies it did not clearly change levels of sex hormones.
Veozah comes as one strength, a 45 mg tablet taken once a day by mouth, with or without food. Take it with liquid at about the same time each day, and swallow it whole; do not cut, crush or chew it. If a dose is missed, take it as soon as you remember, unless the next dose is less than 12 hours away. In that case, skip it and go back to the usual schedule the next day. Do not take two tablets to catch up. Blood tests to check the liver are part of taking Veozah. They are done before the first dose, then monthly for the first three months, and again at six and nine months.
In trials, the side effects reported more often than with a placebo were stomach pain, diarrhea, trouble sleeping, back pain and hot flashes. These were uncommon, each affecting a few percent of people, and many people have none. The main serious risk is liver injury. In trials, about 2 in 100 people had a rise in liver enzymes on blood tests, usually without any symptoms, which is why routine testing matters. Since approval, serious liver injury has been reported, generally within the first 40 days. Stop Veozah and contact your prescriber right away for liver tests if you notice new tiredness, loss of appetite, nausea or vomiting, itching, yellowing of the skin or the whites of the eyes, pale stools, dark urine or pain in the upper belly. In reported cases, liver problems gradually improved after the medicine was stopped.
Veozah carries the FDA's strongest warning, a boxed warning, for liver damage. Your prescriber should not start it if baseline liver tests are clearly abnormal, and will stop it if follow-up tests rise past set limits. It should not be used by people with cirrhosis (advanced liver scarring), severe kidney disease or kidney failure. It also must not be combined with medicines that block CYP1A2, a liver enzyme that breaks fezolinetant down. Blocking that enzyme can raise fezolinetant levels several-fold. Examples include fluvoxamine (an antidepressant often used for OCD), ciprofloxacin (an antibiotic), cimetidine (a heartburn and ulcer medicine) and mexiletine (a heart rhythm medicine). Tell your prescriber and pharmacist about every prescription, over-the-counter medicine and supplement you take, including any new antibiotic. There is no information on use during pregnancy or breastfeeding in people, so discuss either situation with your prescriber.
In the main trials, people starting with about 10 to 12 moderate to severe hot flashes a day had roughly 6 to 7 fewer a day after 12 weeks. People taking a placebo also improved, by about 4 to 5 fewer a day, so the medicine's added benefit was about 2 to 3 fewer hot flashes a day on average, along with somewhat milder episodes. Improvement was already measurable by week 4. Responses vary: some people notice a large change, others very little. The first months involve regular blood draws for liver monitoring. If hot flashes have not improved enough after a fair trial, or side effects are a problem, your prescriber can discuss hormone therapy or another nonhormonal option. Hot flashes often fade over the years after menopause, so it is reasonable to review from time to time whether you still need treatment.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Veozah (Fezolinetant), what you've noticed, or ask the community a question.